Chemical Formula: C6H14N2O3

Chemical Formula C6H14N2O3

Found 59 metabolite its formula value is C6H14N2O3

5-Hydroxylysine

alpha,epsilon-Diamino-delta-hydroxycaproic acid

C6H14N2O3 (162.1004374)


5-Hydroxylysine (Hyl), also known as hydroxylysine or 5-Hydroxy-L-lysine, belongs to the class of organic compounds known as L-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Amino acids are organic compounds that contain amino (–NH2) and carboxyl (–COOH) functional groups, along with a side chain (R group) specific to each amino acid. 5-Hydroxylysine is a hydroxylated derivative of the amino acid lysine that is present in certain collagens, the chief structural protein of mammalian skin and connective tissue. 5-Hydroxylysine arises from a post-translational hydroxy modification of lysine and is biosynthesized from lysine via oxidation by lysyl hydroxylase enzymes. 5-Hydroxylysine can then undergo further modification by glycosylation, giving rise to galactosyl hydroxylysine (GH) and glucosylgalactosyl hydroxylysine (GGH). These glycosylated forms of hydroxylysine contribute to collagen’s unusual toughness and resiliency. The monoglycosylated, galactosyl-hydroxylysine is enriched in bone compared with the disaccharide form, glucosyl-galactosyl-hydroxylysine, which is the major form in skin. 5-Hydroxylysine exists in all eukaryotes, ranging from yeast to humans. It was first discovered in 1921 by Donald Van Slyke. Free forms of hydroxylysine arise through proteolytic degradation of collagen. Urinary excretion of 5-Hydroxylysine and its glycosides can be used as an index of collagen degradation, with high levels being indicative of more rapid or extensive collagen degradation (often seen in patients with thermal burns, Pagets disease of bone or hyperphosphatasia) (PMID: 404321). One of the natural protein-bound amino acids. Occurs free in plant tissues, e.g. Medicago sativa (alfalfa)

   

2-Deoxystreptamine

4,6-diaminocyclohexane-1,2,3-triol

C6H14N2O3 (162.1004374)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents KEIO_ID D061

   

7-hydroxylysine

N(6)-hydroxy-L-lysine

C6H14N2O3 (162.1004374)


   

D-Bacillosamine

Bacillosamine; 2,4-Diamino-2,4,6-trideoxy-D-glucopyranose

C6H14N2O3 (162.1004374)


   

Allohydroxy-L-lysine

allo-Hydroxy-L-lysine

C6H14N2O3 (162.1004374)


   

2-Deoxystreptamine

4,6-diaminocyclohexane-1,2,3-triol

C6H14N2O3 (162.1004374)


   

5-hydroxylysine

(2S,5R)-2,6-Diamino-5-hydroxyhexanoic acid

C6H14N2O3 (162.1004374)


   

N-Nitrosobis(2-hydroxypropyl)amine

1-[(2-hydroxypropyl)(nitroso)amino]propan-2-ol

C6H14N2O3 (162.1004374)


D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens

   

L-2-Amino-4-(2-aminoethoxy)butanoic acid

L-2-Amino-4-(2-aminoethoxy)butanoic acid

C6H14N2O3 (162.1004374)


   

alpha,epsilon-Diamino-alpha-hydroxy-capronsaeure

alpha,epsilon-Diamino-alpha-hydroxy-capronsaeure

C6H14N2O3 (162.1004374)


   
   

2-Amino-4-(2-aminoethoxy)butanoic acid

2-Amino-4-(2-aminoethoxy)butanoic acid

C6H14N2O3 (162.1004374)


   

3,6-diamino-5-hydroxyhexanoic acid

3,6-diamino-5-hydroxyhexanoic acid

C6H14N2O3 (162.1004374)


   

3,6-Diamino-4-hydroxyhexanoic acid

3,6-Diamino-4-hydroxyhexanoic acid

C6H14N2O3 (162.1004374)


   

5-hydroxylysine

L-Erythro-5-hydroxylysine

C6H14N2O3 (162.1004374)


The lysine derivative that is 2,6-diamino-5-hydroxyhexanoic acid, a chiral alpha-amino acid. KEIO_ID H064

   

DL-5-Hydroxylysine

DL-5-Hydroxylysine

C6H14N2O3 (162.1004374)


Acquisition and generation of the data is financially supported in part by CREST/JST.

   

DL-5-Hydroxylysine hydrochloride

2,6-Diamino-5-hydroxycaproic acid

C6H14N2O3 (162.1004374)


   
   

delta-Hydroxylysine

delta-Hydroxylysine

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; LC-tDDA; CE10

5-Hydroxylysine; LC-tDDA; CE10

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; AIF; CE0; CorrDec

5-Hydroxylysine; AIF; CE0; CorrDec

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; AIF; CE10; CorrDec

5-Hydroxylysine; AIF; CE10; CorrDec

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; AIF; CE30; CorrDec

5-Hydroxylysine; AIF; CE30; CorrDec

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; AIF; CE0; MS2Dec

5-Hydroxylysine; AIF; CE0; MS2Dec

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; AIF; CE10; MS2Dec

5-Hydroxylysine; AIF; CE10; MS2Dec

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; AIF; CE30; MS2Dec

5-Hydroxylysine; AIF; CE30; MS2Dec

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; LC-tDDA; CE20

5-Hydroxylysine; LC-tDDA; CE20

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; LC-tDDA; CE30

5-Hydroxylysine; LC-tDDA; CE30

C6H14N2O3 (162.1004374)


   

5-Hydroxylysine; LC-tDDA; CE40

5-Hydroxylysine; LC-tDDA; CE40

C6H14N2O3 (162.1004374)


   
   

N-(2-HYDROXYETHYL)-N-(4-HYDROXYBUTYLNITROSAMINE)

N-(2-HYDROXYETHYL)-N-(4-HYDROXYBUTYLNITROSAMINE)

C6H14N2O3 (162.1004374)


   

Urea, N-(2,2-dimethoxyethyl)-N-methyl- (9CI)

Urea, N-(2,2-dimethoxyethyl)-N-methyl- (9CI)

C6H14N2O3 (162.1004374)


   

Threo-4-hydroxy-L-lysine

Threo-4-hydroxy-L-lysine

C6H14N2O3 (162.1004374)


   
   

(2S,5S)-2,6-diamino-5-hydroxyhexanoic acid

(2S,5S)-2,6-diamino-5-hydroxyhexanoic acid

C6H14N2O3 (162.1004374)


   

4-Hydroxy-l-lysine

4-Hydroxy-l-lysine

C6H14N2O3 (162.1004374)


A hydroxy-L-lysine that is L-lysine carrying a hydroxy substituent at position 4.

   
   

3-Hydroxylysine

(3S)-3-hydroxy-L-lysine

C6H14N2O3 (162.1004374)


   

(2R,5R)-2,6-diamino-5-hydroxyhexanoic acid

(2R,5R)-2,6-diamino-5-hydroxyhexanoic acid

C6H14N2O3 (162.1004374)


   

2-Amino-4-(2-amino-ethoxy)-butyric acid

2-Amino-4-(2-amino-ethoxy)-butyric acid

C6H14N2O3 (162.1004374)


   

(2S)-2-ammonio-6-(hydroxyamino)hexanoate

(2S)-2-ammonio-6-(hydroxyamino)hexanoate

C6H14N2O3 (162.1004374)


   

3,5-Diaminocyclohexane-1,2,4-triol

3,5-Diaminocyclohexane-1,2,4-triol

C6H14N2O3 (162.1004374)


   
   

2,6-diamino-2,3,6-trideoxy-alpha-D-glucose

2,6-diamino-2,3,6-trideoxy-alpha-D-glucose

C6H14N2O3 (162.1004374)


   

N(6)-hydroxy-L-lysine

N(6)-hydroxy-L-lysine

C6H14N2O3 (162.1004374)


   

N-Bis(2-hydroxypropyl)nitrosamine

N-Nitrosobis(2-hydroxypropyl)amine

C6H14N2O3 (162.1004374)


D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens

   

(3S)-3-hydroxy-L-lysine

(3S)-3-hydroxy-L-lysine

C6H14N2O3 (162.1004374)


A L-lysine derivative that is L-lysine substituted at position 3 by a hydroxy group (the 3S-erythro-stereoisomer).

   

erythro-5-Hydroxy-L-lysine

erythro-5-Hydroxy-L-lysine

C6H14N2O3 (162.1004374)


A 5-hydroxylysine consisting of L-lysine having an (R)-hydroxy group at the 5-position.

   

(4R)-4-hydroxy-L-lysine

(4R)-4-hydroxy-L-lysine

C6H14N2O3 (162.1004374)


A 4-hydrox-L-lysine that is L-lysine substituted at position 4 by a hydroxy group (the 4R-threo-stereoisomer).

   

N(6)-hydroxy-L-lysine zwitterion

N(6)-hydroxy-L-lysine zwitterion

C6H14N2O3 (162.1004374)


Zwitterionic form of N(6)-hydroxy-L-lysine having an anionic carboxy group and a cationic amino group; major species at pH 7.3.

   

N(6)-Hydroxy-lysine

N(6)-Hydroxy-lysine

C6H14N2O3 (162.1004374)


   
   

2,5-diamino-2-hydroxyhexanoic acid

2,5-diamino-2-hydroxyhexanoic acid

C6H14N2O3 (162.1004374)


   

n-(2-hydroxyethyl)-2-[(2-hydroxyethyl)amino]ethanimidic acid

n-(2-hydroxyethyl)-2-[(2-hydroxyethyl)amino]ethanimidic acid

C6H14N2O3 (162.1004374)


   

(2s)-2-amino-4-(2-aminoethoxy)butanoic acid

(2s)-2-amino-4-(2-aminoethoxy)butanoic acid

C6H14N2O3 (162.1004374)


   

(2s)-6-amino-2-(hydroxyamino)hexanoic acid

(2s)-6-amino-2-(hydroxyamino)hexanoic acid

C6H14N2O3 (162.1004374)


   

(1r,3s,4r,6s)-4,6-diaminocyclohexane-1,2,3-triol

(1r,3s,4r,6s)-4,6-diaminocyclohexane-1,2,3-triol

C6H14N2O3 (162.1004374)


   

(2r,5s)-2,5-diamino-2-hydroxyhexanoic acid

(2r,5s)-2,5-diamino-2-hydroxyhexanoic acid

C6H14N2O3 (162.1004374)